Course Provider
Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.
Linked Courses
2
Active Listings
0
Primary Formats
Hybrid, Self-paced
Programs linked directly to this provider in the Blossom course dataset.
By Mind Medicine Australia
The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Source lists: Estimated 121 hours
Delivery: Online + Australia
By Mind Medicine Australia
The Fundamentals of Psychedelic-Assisted Therapy for Mental Health is a 4-part online training program designed to educate medical and mental health professionals, individuals with lived experience, and consumers on the science and clinical use of psychedelics.
Source lists: 15 hours
Delivery: Self-paced + Online